Condition
Liver Metastases clinical trials and research
As of November 12, 2026, Find a Trial lists 51 Liver Metastases clinical trials that are recruiting, at sites in 21 countries (most in United States (16), Netherlands (8), China (8)). By phase: Phase 3 (10), Phase 2 (9), Phase 1/2 (4), Phase 2/3 (3). The most active sponsors are Amsterdam UMC, location VUmc (3), Sixth Affiliated Hospital, Sun Yat-sen University (3), Oslo University Hospital (2). There are also 11 NIH-funded research projects on Liver Metastases, with $5.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 51Clinical trials
- 11NIH research projects
- 21Countries
Newest Liver Metastases clinical trials
All recruiting trials (51)
-
Prospective look at liver metastases imaging and tissue patterns in colorectal and breast cancer
This observational study tests whether 3D maps of histopathological growth patterns in liver metastases align with imaging features from MRI/CT in patients undergoing liver surgery.
-
Predicting liver failure after major liver surgery using CT measurements and vascular shape changes
Doctors are testing whether adding vascular deformation mapping to CT measurements can better predict liver failure after removing a large portion of the liver.
-
DRAGON: International registry for patients who had combined portal and hepatic vein embolization before liver surgery
This registry collects data on patients who had PVE/HVE before liver resection to see if it helps liver regeneration and what factors relate to outcomes.
-
Metastatic liver cancer patient registry from multiple Chinese centers
This is a registry that collects real-world data on adults with liver metastases to understand patterns and prognosis and to support future research.
-
HEPZATO KIT with Opdualag for metastatic melanoma that has spread to the liver
This will try adding HEPZATO KIT to Opdualag (nivolumab + relatlimab) to see if it's safe and helps people with metastatic melanoma that has spread to the liver.
-
Neoadjuvant immunotherapy with Dupilumab and Toripalimab for MSS colorectal cancer with resectable liver metastases
This study tests a pre-surgery treatment combining dupilumab and toripalimab in adults with microsatellite-stable colorectal cancer that has liver metastases, to see if it’s safe and can lead to major tumor response.
-
Boosting immunotherapy with low-dose liver radiation
This trial tests whether adding low-dose radiation to the liver before immunotherapy helps people with melanoma or non-small cell lung cancer who have liver metastases live longer without their disease worsening.
-
MRI-guided adaptive single-session radiation for liver tumors (SABR)
This trial will test a single-session, MRI-guided adaptive high-dose radiation (SABR) for adults with primary or metastatic liver tumors to see if on-table MRI planning and replanning can treat tumors without a separate simulation visit.
-
CRISPR-edited donor liver transplant to reduce rejection
This trial will try transplanting deceased-donor livers that have had key HLA genes removed with CRISPR to see if they cause less rejection in adults needing a liver transplant.
-
Histotripsy plus chemotherapy versus chemotherapy alone for colorectal cancer spread to the liver
This trial will test whether adding noninvasive histotripsy to standard chemotherapy helps people with unresectable, liver‑confined colorectal cancer metastases stay free of disease progression longer.
-
Liver function after stereotactic body radiotherapy (SBRT)
This project will use a special liver scan (HEBIS) before and after SBRT to see how different radiation doses affect liver function in people treated for liver metastases.
-
Assessing blood biomarkers and MRI for liver cancer patients undergoing radiation therapy
This study is testing if using special MRI scans and blood tests can help doctors keep track of liver health in patients with liver cancer who are getting radiation therapy.
-
Treatment for liver metastases from colorectal cancer using a combination of therapies
This study is testing if a new combination of treatments for liver cancer from colorectal cancer can help patients live longer compared to the standard treatment they would usually receive.
-
Combining radiation therapy and PD-1 antibody for liver metastases from colorectal cancer
This study is testing if combining a special type of radiation therapy with a new immune treatment can help people with liver cancer from colorectal cancer feel better and live longer.
-
Evaluating a new immuno-adjuvant for colorectal liver metastases after ablation treatments
This study is testing a new treatment called IP-001 to see if it can boost the immune response and help people with colorectal liver metastases feel better after they have undergone ablation therapies.
-
Combination treatment for liver metastases from uveal melanoma
This study is testing a new combination treatment for patients with liver metastases from uveal melanoma to see if adding a special delivery method can help them live longer without their cancer getting worse.
-
Ultra-high dose MR-guided single-session radiation for liver metastases
This trial will test whether one very high‑dose MR‑guided radiation session works better than a high‑dose approach for adults with up to three liver metastases.
-
Testing immunotherapy combinations for colorectal cancer that has spread to the liver
This study is testing different combinations of immunotherapy treatments for people with colorectal cancer that has spread to the liver to see if they can improve treatment results before surgery.
-
ctDNA blood tests to guide treatment in colorectal cancer with liver metastases
A study using blood tests that look for tumor DNA to help decide which patients with colorectal cancer that has spread to the liver need more treatment after surgery.
-
Combining Serplulimab and Bevacizumab with FOLFOX for Colorectal Cancer Treatment
This study is testing if adding two new drugs to standard chemotherapy can help people with colorectal cancer that has spread to the liver live longer and have fewer chances of the cancer coming back after surgery.
-
Comparing simultaneous and staged surgery for colorectal cancer with liver metastases
This study is testing whether doing surgery for colon cancer and liver tumors at the same time or in separate stages is better for patients in terms of recovery and overall health.
-
Comparing two treatments for colorectal liver metastases
This study is testing whether a new treatment called irreversible electroporation works better than stereotactic body radiotherapy for people with hard-to-treat colorectal cancer that has spread to the liver.
-
Using AI to improve treatment for liver tumors
This study is testing whether using artificial intelligence can help doctors choose the best treatments and predict outcomes for patients with liver tumors undergoing thermal ablation.
-
High-dose MRI-guided radiation therapy for liver cancer from colorectal cancer
This study is testing if a single high-dose radiation treatment guided by MRI can help people with liver cancer caused by colorectal cancer by stopping the growth of tumors and seeing how well it works based on MRI images.
-
Comparing surgery and medical treatment for breast cancer that has spread to the liver
This study is testing whether surgery or just medical treatment works better for people with breast cancer that has spread to the liver.
-
Comparing methods to increase liver size before surgery
This study is testing three different ways to help increase liver size before surgery for patients with liver tumors to see which method works best.
-
Neoadjuvant therapy followed by local treatment for recurrent colorectal liver metastases
This study is testing if giving a new treatment before local therapy can help people with recurrent colorectal liver cancer live longer compared to getting local therapy right away.
-
Using Alpha Radiation to Treat Liver Metastases
This study is testing a new treatment using alpha radiation to see if it can safely target and shrink liver tumors in patients with liver metastases.
-
Comparing chemotherapy and observation for liver metastasis in colorectal cancer
This study is testing if some patients with liver metastasis from colorectal cancer can safely skip chemotherapy after surgery and just be monitored instead.
-
Maintenance therapy for colorectal cancer patients after liver surgery
This study is testing if adding maintenance therapy to standard chemotherapy can help colorectal cancer patients with liver metastases live longer without their cancer getting worse after surgery.
-
Improving recovery after surgery with intravenous iron treatment
This study tests if giving intravenous iron to patients who lose a lot of blood during major surgeries can help them recover better and need fewer blood transfusions.
-
Combining Bevacizumab with Chemoimmunotherapy for Advanced Lung Cancer with Liver Metastases
This study is testing whether adding a drug called bevacizumab to a combination of chemotherapy and another treatment can help people with advanced lung cancer that has spread to the liver live longer and feel better.
-
Using MRI to Improve Surgery Selection for Pancreatic Cancer Patients
This study is testing whether using MRI along with CT scans can help doctors better decide if surgery is a good option for pancreatic cancer patients with possible liver spread.
-
Liver transplantation for patients with non-resectable colorectal liver metastases
This study is testing whether liver transplantation can help patients with colorectal cancer that has spread to the liver when surgery isn't an option.
-
Using ctDNA to guide chemotherapy after liver surgery for colorectal cancer
This study is testing if checking for tumor DNA in the blood after liver surgery for colorectal cancer can help doctors decide the best follow-up treatment for patients to prevent the cancer from coming back.
-
Cryoablation with Sintilimab and Regorafenib for Liver Metastases from Colorectal Cancer
This study is testing if combining a freezing treatment with two medications can help people with liver cancer from colorectal cancer who haven't responded to previous treatments.
-
Neoantigen vaccine combined with nivolumab for liver cancer treatment
This study is testing a personalized vaccine combined with a cancer drug to see if it can help people with liver cancer stay cancer-free after surgery.
-
Intra-arterial liver infusion of radiolabeled somatostatin drugs for gastroenteropancreatic neuroendocrine tumors with dominant liver metastases
This will test whether giving radiolabeled somatostatin medication directly into the liver works better than the usual IV route for people with gastroenteropancreatic neuroendocrine tumors whose disease mainly affects the liver after four Lutathera treatments.
-
Comparing standard and guided radiation therapy for liver cancer
This study is testing if a new way of guiding radiation therapy can help people with liver cancer get better results and less damage to healthy tissue compared to the standard method.
-
Treatment for colorectal cancer patients with liver metastases that can't be surgically removed
This study is testing two different treatment combinations to see which one helps colorectal cancer patients with liver tumors that can’t be removed by surgery live longer and possibly make their tumors operable.
-
Liver transplantation for patients with colorectal cancer that has spread to the liver
This study looks at whether liver transplants can help patients with colorectal cancer that has spread only to the liver live longer if their cancer was well-controlled by chemotherapy before the transplant.
-
Improving fitness during chemotherapy for liver cancer patients
This study is testing a 16-week program that combines exercise, nutrition, and support to see if it helps liver cancer patients feel fitter during chemotherapy and before surgery compared to those who only get support right before surgery.
-
Analyzing liver tumor tissue after ablation to guide further treatment
This study is testing if looking at liver tumor samples after treatment can help doctors decide the best next steps for patients with liver cancer.
-
Using MRI to guide radiation therapy for various cancers
This study is testing if using MRI scans to adjust radiation therapy can help people with different types of cancer, like pancreatic and lung cancer, feel better and control their tumors more effectively.
-
Local treatment for breast cancer that has spread to the liver
This study is testing whether surgery for liver cancer that has spread from breast cancer can help patients live longer and feel better compared to regular treatments.
-
Evaluating the impact of MR-guided radiation therapy on cancer treatment outcomes
This study is testing how using a special type of radiation therapy with real-time imaging can improve treatment results and quality of life for adults with cancer.
-
MRI‑guided, dose‑escalated SBRT for liver and nearby bowel metastases
This trial will try giving higher, MRI‑guided stereotactic radiation doses to people with liver or adjacent bowel metastases to find the safest maximum dose.
-
Comparing liver transplantation to chemotherapy for colorectal cancer patients with liver metastases
This study is testing whether liver transplantation works better than chemotherapy for colorectal cancer patients whose liver cancer can't be surgically removed.
-
Liver transplantation for patients with colorectal cancer liver metastases
This study is testing a new approach that combines surgery and liver transplantation to see if it can help patients with colorectal cancer that has spread to the liver live longer compared to standard chemotherapy.
-
Using targeted radiation therapy for liver tumors that can't be surgically removed
This study is testing if a special type of radiation therapy can help patients with certain types of cancer who have liver tumors that can't be surgically removed.
-
Using proton therapy to treat liver metastases
This study is testing if proton therapy can help control hard-to-treat liver metastases better than traditional methods for patients who have limited treatment options.
NIH-funded research (11)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
TREM2+ macrophages and liver metastases in pancreatic cancer
Researchers are studying immune cells in liver metastases from pancreatic cancer to understand how they influence the cancer’s spread and more effective treatments.
-
Immune regulation in colon cancer and its spread to lymph nodes and liver
A patient-friendly look at how immune system circuits in colorectal cancer and its metastases may influence treatment responses and outcomes.
-
Ablating Liver Metastases with SBRT to Boost Immunotherapy in Melanoma
Aims to see if targeted liver radiation plus two immunotherapy drugs helps people with melanoma that has spread to the liver.
-
Targeting stress defenses in eye melanoma that spreads to the liver
Researchers are working to weaken tumor cells' defenses against oxidative damage so liver metastases from uveal (eye) melanoma in adults become more vulnerable to treatment.
-
Exercise before liver surgery to lower colorectal cancer recurrence
Exercise before liver surgery aims to calm harmful immune responses and reduce the chance colorectal cancer comes back in the liver for people with liver metastases.
-
Immune cell circuits in primary colon tumors and their lymph node and liver metastases
This project looks at how immune cells and their neighborhoods behave in people with the common pMMR form of colon cancer to find ways to make immunotherapy work better.
-
Exploring how surgery affects the immune response and liver cancer spread
This study is looking at how exercise before surgery can help people with colorectal cancer that has spread to the liver by boosting their immune system and reducing inflammation, which might lead to better recovery and lower chances of cancer coming back.
-
Understanding how liver conditions affect uveal melanoma spread
This study is looking at how uveal melanoma, a serious eye cancer that can spread to the liver, grows in that environment, with the hope of finding new treatments to help patients live longer and better.
-
Understanding immune interactions in colon cancer and its spread to lymph nodes and liver
This study is looking at how certain immune cells behave in colon cancer and its spread to lymph nodes and the liver, to help understand why some patients don’t respond well to treatments, and it’s for people with colorectal cancer.
-
Improving MRI technology to detect liver tumors earlier
This study is working on improving MRI scans to help doctors find small liver tumors in people with colorectal cancer more easily, which could lead to quicker and better treatment options for patients.
-
Identifying imaging markers to predict treatment response and recurrence in colorectal liver cancer
This study is looking to find new ways to use regular CT scans to help predict how well patients with colorectal liver cancer will respond to treatment and their chances of the cancer coming back, so that doctors can tailor treatments to each person's needs.
Related topics
Quick answers
How many Liver Metastases clinical trials are recruiting right now?
51, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 21 countries. The most sites are in United States (16 trials), Netherlands (8 trials), China (8 trials), Canada (5 trials), Spain (4 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 10, Phase 2: 9, Phase 1/2: 4, Phase 2/3: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.